Table 2.
AKI models in Nlrp3-, Asc-, Casp1/11-, Il-1α–, and Il-β–deficient mice
| Disease Model | Gene | Inflammation | Renal Function | Reference |
|---|---|---|---|---|
| Severe GN | ||||
| Heterologous anti-GBM GN | Nlrp3−/− | — | — | 63 |
| Asc−/− | — | — | 63 | |
| Casp1/11−/− | — | — | 63 | |
| Autologous anti-GBM GN | Nlrp3−/− | ↓ | Better | 86 |
| Asc−/− | ↓ | Better | 86 | |
| IL1β−/− | ↓ | Better | 84,85 | |
| Sepsis | ||||
| LPS-induced | Casp1/11−/− | ↓ | Better | 120 |
| Tubular necrosis | ||||
| Ischemia- reperfusion | Nlrp3−/− | — | Better | 76,77,79 |
| Asc−/− | — | — | 76 | |
| Casp1/11−/− | ↓ | Better | 121 | |
| IL1α−/− | ↓ | ? | 122 | |
| IL1β−/− | ↓ | ? | 122 | |
| Cisplatin | Nlrp3−/− | — | — | 79 |
| Asc−/− | ? | ? | 123 | |
| Casp1/11−/− | ↓ | Better | 118 | |
| IL1α−/−- | — | Better | 80 | |
| Rhabdomyolysis | Nlrp3−/− | ↓ | Better | 75 |
| Asc−/− | ↓ | Better | 75 | |
| Casp1/11−/− | ↓ | Better | 75 | |
| IL1β−/− | ↓ | Better | 75 | |
| Acute oxalosis | Nlrp3−/− | ↓ | Better | 21 |
| Asc−/− | ↓ | Better | 21 | |
| Casp1/11−/− | ↓ | Better | 21 | |
Anti-GBM GN, anti-glomerular basement membrane GN; —, absent; ↓, suppressed; ?, unknown.